Hjem › Alzheimers sykdom › Arizona
Kliniske studier for Alzheimers sykdom i Arizona
23 studier for Alzheimers sykdom søker deltakere på steder i Arizona.
Byer i Arizona
Offisiell studietekst (engelsk)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Phoenix
- Clinical Site, Scottsdale
- Clinical Site, Tucson
RekruttererFase 2
Alder 55 til 90 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06887192A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 2609, Chandler
- Imaging Endpoints, Scottsdale
RekruttererFase 3
Alder 55 til 90 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06937229A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Gilbert Neurology Partners - PLLC - Avacare, Gilbert
- Banner Alzheimer's Institute, Phoenix
RekruttererFase 3
Alder 55 til 90 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06585787A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- TrialSphere Corp, Chandler
- HonorHealth Research Institute, Scottsdale
RekruttererFase 2
Alder 55 til 85 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07589595Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Banner Alzheimer's Institute, Phoenix
- Barrow Neurological Institute, Phoenix
- Clinical Endpoints, Scottsdale
RekruttererFase 2
Alder 55 til 80 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT06847321Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Banner Alzheimer?s Institute, Phoenix
- Banner Sun Health Research Institute, Sun City
RekruttererFase 3
Alder 50 til 90 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07177352A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Imaging Endpoints, Scottsdale
RekruttererFase 3
Alder 55 til 90 · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07011732A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Chandler Clinical Trials, LLC, Chandler
- Local Institution - 2631, Chandler
- TrialSphere Corp, Chandler
RekruttererFase 3
Alder 55 til 90 · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07011745Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Local Institution - 0040, Scottsdale
RekruttererFase 2
Alder 55 til 90 · Alle kjønn · Oppdatert 1. sep. 2026 · NCT06808984A Study of AMDX-2011P in Participants With Alzheimer's Disease
- Associated Retina Consultants, Phoenix
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 31. aug. 2026 · NCT06514001The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study
- University of Arizona, Tucson
Rekrutterer
Alder 55 til 85 · Alle kjønn · Oppdatert 6. aug. 2026 · NCT05988385Goal Setting to Promote Physical Activity Adherence in Midlife Adults
- Arizona State University, Phoenix
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 45 til 65 · Alle kjønn · Oppdatert 17. jul. 2026 · NCT05980052A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Banner Alzheimer's Institute, Phoenix
RekruttererFase 3
Alder 55 og eldre · Alle kjønn · Oppdatert 7. jul. 2026 · NCT07602582A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
- Gilbert Neurology Partners/CCT Research, Gilbert
RekruttererFase 3
Alder 55 til 90 · Alle kjønn · Oppdatert 30. jun. 2026 · NCT06947941A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- Banner Alzheimers Institute, Phoenix
RekruttererFase 2
Alder 50 til 85 · Alle kjønn · Oppdatert 26. jun. 2026 · NCT07094516[18F]PI-2620 Phase 3 Histopathological Study
- Barrow Neurological Institute, Phoenix
- Banner Sun Health Research Institute, Sun City
RekruttererFase 3
Alder 50 og eldre · Alle kjønn · Oppdatert 22. mai 2026 · NCT05641688Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Barrow Neurological Institute, Phoenix
RekruttererObservasjonsstudie
Alder 25 til 55 · Alle kjønn · Oppdatert 18. mai 2026 · NCT04165109A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses
- Arizona State University, Phoenix
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 65 og eldre · Alle kjønn · Oppdatert 5. mai 2026 · NCT05877196Early-Stage Partner in Care Living Alone Plus
- Arizona State University, Phoenix
Rekrutterer
Alder 60 og eldre · Alle kjønn · Oppdatert 27. mar. 2026 · NCT06962111Repurposing Siponimod for Alzheimer's Disease
- St. Joseph's Hospital and Medical Center, Phoenix
RekruttererFase 2
Alder 50 til 85 · Alle kjønn · Oppdatert 4. mar. 2026 · NCT06639282A Study of Neurodegeneration and Neuronal Fluctuations in Lewy Body Disease and Alzheimer's Disease
- Mayo Clinic Arizona, Scottsdale
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 50 til 95 · Alle kjønn · Oppdatert 3. feb. 2026 · NCT06057909Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies
- Banner Alzheimer's Institute, Phoenix
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 til 110 · Alle kjønn · Oppdatert 16. des. 2025 · NCT02022943PROMIS and Mobility Evaluation in Sarcoma Patients
- Mayo Clinic, Phoenix
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 13. nov. 2025 · NCT07227961Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.